Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | Immune escape mechanisms in human cancers

Jérôme Galon • 14 Oct 2021
EORTC CLTF 2021
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases

Jérôme Galon, MD, PhD, Inserm, Paris, France, outlines immune escape mechanisms, highlighting the importance of adaptive immunity and commenting on the role of immunosuppressive mechanisms in human cancers. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Jérôme Galon

1:05
The future of immuno-oncology
Jérôme Galon • 14 Oct 2021
2:25
The prognostic value of memory T-cell reactions
Jérôme Galon • 14 Oct 2021
1:20
The cancer immune contexture
Jérôme Galon • 14 Oct 2021
1:36
Immunoscore®: classifying patients based on immune characteristics
Jérôme Galon • 14 Oct 2021

Related Videos

1:24
Employing CAR-T therapies in earlier lines of large B-cell lymphoma treatment
Paolo Cortesi • 24 Apr 2024
2:45
The value of axi-cel as a second-line treatment in R/R LBCL
Paolo Cortesi • 24 Apr 2024
5:42
Promising therapeutic efficacy of EBV-specific T-cell immunotherapy tabelecleucel in PTLD
Nina Worel • 25 Apr 2024
4:24
Investigating production failure and out-of-specification production of CAR T-cell therapeutics
Nina Worel • 25 Apr 2024
The content of VJHemOnc is intended for healthcare professionals